Latest filing published 27 May 2016 for Inhibitor Therapeutics, Inc..
Insider track record
No signal scores available.
Mayne Pharma Group Ltd: trading record in brief
Mayne Pharma Group Ltd discloses dealings in Inhibitor Therapeutics, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 15 May 2015 to 25 May 2016.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 27 May 2016, reports a share grant in Inhibitor Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mayne Pharma Group Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 27,885,000 sharesCommon StockSEC:0001560183-16-000003:0
- 33,333,333 sharesCommon StockSEC:0001560183-15-000001:0
2 of 2 declarations